In the last trading session, 0.13 million shares of the Matinas Biopharma Holdings Inc (AMEX:MTNB) were traded, and its beta was 1.58. Most recently the company’s share price was $0.57, and it changed around $0.01 or 3.02% from the last close, which brings the market valuation of the company to $2.91M. MTNB currently trades at a discount to its 52-week high of $21.50, offering almost -3671.93% off that amount. The share price’s 52-week low was $0.48, which indicates that the current value has risen by an impressive 15.79% since then. We note from Matinas Biopharma Holdings Inc’s average daily trading volume that its 10-day average is 1.82 million shares, with the 3-month average coming to 519.06K.
Matinas Biopharma Holdings Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended MTNB as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Matinas Biopharma Holdings Inc (AMEX:MTNB) trade information
Instantly MTNB has showed a green trend with a performance of 3.02% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9900 on recent trading dayincreased the stock’s daily price by 42.42%. The company’s shares are currently up 12.35% year-to-date, but still down -7.58% over the last five days. On the other hand, Matinas Biopharma Holdings Inc (AMEX:MTNB) is 6.09% up in the 30-day period. We can see from the shorts that 32365.0 shares have been sold at a short interest cover period of 0.19 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 7.12%.
MTNB Dividends
Matinas Biopharma Holdings Inc’s next quarterly earnings report is expected to be released in February.
Matinas Biopharma Holdings Inc (AMEX:MTNB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.49% of Matinas Biopharma Holdings Inc shares, and 26.08% of them are in the hands of institutional investors. The stock currently has a share float of 26.75%. Matinas Biopharma Holdings Inc stock is held by 25.0 institutions, with HIGHBRIDGE CAPITAL MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 4.8971% of the shares, which is about 10.64 million shares worth $1.68 million.
VANGUARD GROUP INC, with 4.2869% or 9.32 million shares worth $1.48 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
